This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The IPO Market's Post-Facebook Reality

Meantime, Avast Software saw the dark clouds gathering for cloud companies and withdrew its IPO altogether. Avast is a popular security software and its planned pricing was aiming for a valuation of more than $800 million. It produced only revenues of $91 million last year and net income of $27 million.

It seems the cloud companies have to go back to the drawing board for their price valuations. Take a lesson from the pharma companies that have gone public lately. Price low and then you have somewhere to go. The market will perceive your deal as a bargain.

Hyperion Therapeutics (HPTX) priced its stock at $10 on July 26, below its planned range of $11-$13. The stock is already in positive territory. Supernus Pharmaceuticals (SUPN - Get Report) priced at $5 and the stock is up 157%. It was originally looking at a range of $12-$14.

Also, what if we change the way we look at LegalZoom? Instead of thinking of it as tech offering, let's think of it as a consumer service company, like Kayak (KYAK). On Kayak consumers walk away with something in their hand -- an airline ticket. On LegalZoom they walk away with a document like a will. Kayak is up 29%.

So let's price it like a pharma and call it a consumer service company. That approach might set LegalZoom up for a successful offering.

Unless they get creative, digital companies going public in the post-Facebook era will be fighting against the unforgiving forces of marketplace.

-- Written by Debra Borchardt in New York.



>To contact the writer of this article, click here: Debra Borchardt.

>To follow the writer on Twitter, go to http://twitter.com/wallandbroad.

>To submit a news tip, send an email to: tips@thestreet.com.

Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG
FB $81.05 0.71%
EOPN $8.59 0.00%
HPTX $45.99 0.04%
SUPN $13.41 1.10%
AAPL $132.81 1.10%

Markets

DOW 18,265.15 -20.59 -0.11%
S&P 500 2,130.88 +0.06 0.00%
NASDAQ 5,103.1460 +12.3520 0.24%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs